Human Genome rallies against biotech downturn
March 10, 2011 at 12:46 PM EST
New FDA-approved lupus treatment rallies shares as large-cap drug makers fuel broader market declines.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|